Fonte: Current Pharmaceutical Design. Unidade: FCFRP
Assuntos: TRIPANOSSOMICIDAS, LEISHMANIA, TRYPANOSOMA CRUZI
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINHEIRO, Matheus Pinto e EMERY, Flavio da Silva e NONATO, Maria Cristina. Target sites for the design of anti-trypanosomatid drugs based on the structure of dihydroorotate dehydrogenase. Current Pharmaceutical Design, v. 19, n. 14, p. 2615-2627, 2013Tradução . . Disponível em: https://doi.org/10.2174/1381612811319140011. Acesso em: 16 nov. 2025.APA
Pinheiro, M. P., Emery, F. da S., & Nonato, M. C. (2013). Target sites for the design of anti-trypanosomatid drugs based on the structure of dihydroorotate dehydrogenase. Current Pharmaceutical Design, 19( 14), 2615-2627. doi:10.2174/1381612811319140011NLM
Pinheiro MP, Emery F da S, Nonato MC. Target sites for the design of anti-trypanosomatid drugs based on the structure of dihydroorotate dehydrogenase [Internet]. Current Pharmaceutical Design. 2013 ; 19( 14): 2615-2627.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612811319140011Vancouver
Pinheiro MP, Emery F da S, Nonato MC. Target sites for the design of anti-trypanosomatid drugs based on the structure of dihydroorotate dehydrogenase [Internet]. Current Pharmaceutical Design. 2013 ; 19( 14): 2615-2627.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/1381612811319140011
